Purple Biotech (PPBT) Short term Debt (2017 - 2020)

Purple Biotech (PPBT) has 4 years of Short term Debt data on file, last reported at $24.4 million in Q2 2020.

• Short term Debt for Q2 2020 came in at $24.4 million, up 895.63% year-over-year; the trailing twelve-month figure through Jun 2020 was $24.4 million (up 895.63% YoY), and the FY2018 annual result was $554000.0, down 72.47% from the prior year.
• Short term Debt improved to $24.4 million in Q2 2020 per PPBT's latest filing, from $2.5 million in the prior quarter.
• Over five years, Short term Debt peaked at $24.4 million in Q2 2020 and troughed at $554000.0 in Q4 2018.
• A 4-year average of $5.8 million and a median of $2.2 million in 2017 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2018 and 2020: Short term Debt slumped 72.47% in 2018, then surged 895.63% in 2020.
• A 4-year view of Short term Debt shows it stood at $2.0 million in 2017, then tumbled by 72.47% to $554000.0 in 2018, then surged by 342.42% to $2.5 million in 2019, then surged by 895.63% to $24.4 million in 2020.
• Business Quant data shows PPBT's Short term Debt at $24.4 million in Q2 2020, $2.5 million in Q2 2019, and $554000.0 in Q4 2018.